| ADHD | Attention-deficit/hyperactivity disorder |
| AMPK | AMP-activated protein kinase |
| BBB | Blood-brain barrier |
| CI | Confidence interval |
| COPD | Chronic obstructive pulmonary disease |
| DALYs | Disability-adjusted life years |
| DUOX1 | Dual oxidase 1 |
| GBD | Global Burden of Disease |
| GSH | Glutathione |
| HR | Hazard ratio |
| ICAM-1 | Intercellular adhesion molecule 1 |
| IL | Interleukin |
| IFN-γ | Interferon gamma |
| iNOS | Inducible nitric oxide synthase |
| IRR | Incidence rate ratio |
| LDL | Low-density lipoprotein |
| MCP-1 | Monocyte chemotactic protein 1 (CCL2) |
| MDA | Malondialdehyde |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLRP3 | NLR family pyrin domain containing 3 |
| NO | Nitric oxide |
| NOX | NADPH oxidase isoform |
| Nrf2 | Nuclear factor E2 related factor-2 |
| OR | Odds ratio |
| PPAR γ | Peroxisome proliferator-activated receptor gamma |
| p47phox | Regulatory subunit of NOX-2 and NOX-1 |
| ROS | Reactive oxygen species |
| RR | Relative risk |
| SOD | Superoxide dismutase |
| TGF- β | Transforming growth factor beta |
| TNFα | Tumor necrosis factor alpha |
| Trx | Thioredoxin |
| US | United States |
| VCAM-1 | Vascular cell adhesion molecule 1 |
| WHO | World Health Organization |